Atrás
Rango del Día
$29.13
$30.16
Rango de 52 Semanas
$25.17
$36.32
Volumen
3,294,408
Promedio 50D / 200D
$31.35
/
$29.72
Cierre Anterior
$29.37
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 20.6 | 0.2 |
| P/B | 2.7 | 3.0 |
| ROE % | 14.7 | 3.5 |
| Net Margin % | 16.4 | 3.8 |
| Rev Growth 5Y % | 5.9 | 9.7 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$46.83
+56.5%
Low: $43.00
High: $56.00
EPS Futuro
-$0.31
Ingresos Est.
1.79B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$3.17
$3.06 – $3.39
|
2.51B | 4 |
| FY2029 |
$2.18
$2.10 – $2.33
|
2.27B | 4 |
| FY2028 |
$1.45
-$0.26 – $3.89
|
2.01B | 10 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | $0.41 | $0.46 | +12.1% |
| 2025-10-28 | $0.42 | $0.49 | +16.7% |
| 2025-07-29 | $0.41 | $0.52 | +26.8% |
| 2025-05-01 | $0.25 | $0.13 | -48.9% |
| 2025-02-12 | $0.81 | $1.04 | +28.4% |
| 2024-10-24 | $0.74 | $0.72 | -2.7% |
| 2024-07-24 | $0.70 | $0.70 | 0.0% |
| 2024-05-01 | $0.59 | $0.44 | -25.4% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Puntos Clave
Revenue grew 5.89% annually over 5 years — modest growth
Earnings declined -34.16% over the past year
ROE of 14.72% — decent returns on equity
Net margin of 16.37% shows strong profitability
Debt/Equity of 0.04 — conservative balance sheet
Generating 480.33M in free cash flow
Crecimiento
Revenue Growth (5Y)
5.89%
Revenue (1Y)-5.25%
Earnings (1Y)-34.16%
FCF Growth (3Y)16.60%
Calidad
Return on Equity
14.72%
ROIC10.08%
Net Margin16.37%
Op. Margin17.21%
Seguridad
Debt / Equity
0.04
Current Ratio3.55
Interest Coverage20.69
Valoración
P/E Ratio
20.63
Forward P/EN/A
P/B Ratio2.74
EV/EBITDA15.50
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -5.25% | Revenue Growth (3Y) | -5.80% |
| Earnings Growth (1Y) | -34.16% | Earnings Growth (3Y) | -17.58% |
| Revenue Growth (5Y) | 5.89% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.48B | Net Income (TTM) | 241.66M |
| ROE | 14.72% | ROA | 9.55% |
| Gross Margin | 86.31% | Operating Margin | 17.21% |
| Net Margin | 16.37% | Free Cash Flow (TTM) | 480.33M |
| ROIC | 10.08% | FCF Growth (3Y) | 16.60% |
| Safety | |||
| Debt / Equity | 0.04 | Current Ratio | 3.55 |
| Interest Coverage | 20.69 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 20.63 | Forward P/E | N/A |
| P/B Ratio | 2.74 | P/S Ratio | 3.38 |
| PEG Ratio | -0.56 | Forward PEG | N/A |
| EV/EBITDA | 15.50 | Fwd EV/EBITDA | 10.35 |
| Forward P/S | 2.78 | Fwd Earnings Yield | N/A |
| FCF Yield | 9.63% | ||
| Market Cap | 4.99B | Enterprise Value | 3.94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.48B | 1.56B | 1.66B | 1.11B | 1.17B |
| Net Income | 241.66M | 367.07M | 355.76M | -158.27M | -48.17M |
| EPS (Diluted) | 1.43 | 2.17 | 2.10 | -0.97 | -0.30 |
| Gross Profit | 1.27B | 1.31B | 1.41B | 893.73M | 976.43M |
| Operating Income | 253.96M | 420.64M | 414.12M | -6.09M | 97.75M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.53B | 2.06B | 2.14B | 1.96B | 2.02B |
| Total Liabilities | 710.96M | 590.59M | 933.54M | 920.23M | 911.90M |
| Shareholders' Equity | 1.82B | 1.46B | 1.20B | 1.04B | 1.11B |
| Total Debt | 70.00M | 75.54M | 372.19M | 379.44M | 416.21M |
| Cash & Equivalents | 1.12B | 291.15M | 457.47M | 292.47M | 337.54M |
| Current Assets | 1.93B | 1.42B | 1.49B | 1.13B | 1.06B |
| Current Liabilities | 543.44M | 465.20M | 520.22M | 497.74M | 471.29M |